CL2011002334A1 - Vacuna recombinante contra infeccion por caligid ( piojo marino ) en peces que comprende proteinas de secrecion similares a vitellogenina ( sep ). (divisional solicitud n° 1917-05) - Google Patents

Vacuna recombinante contra infeccion por caligid ( piojo marino ) en peces que comprende proteinas de secrecion similares a vitellogenina ( sep ). (divisional solicitud n° 1917-05)

Info

Publication number
CL2011002334A1
CL2011002334A1 CL2011002334A CL2011002334A CL2011002334A1 CL 2011002334 A1 CL2011002334 A1 CL 2011002334A1 CL 2011002334 A CL2011002334 A CL 2011002334A CL 2011002334 A CL2011002334 A CL 2011002334A CL 2011002334 A1 CL2011002334 A1 CL 2011002334A1
Authority
CL
Chile
Prior art keywords
caligid
vitellogenin
sep
fish
vaccine against
Prior art date
Application number
CL2011002334A
Other languages
English (en)
Inventor
Neil W Ross
Stewart C Johnson
Mark D Fast
Kathryn Vanya Ewart
Original Assignee
Nat Res Council Canada
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Council Canada filed Critical Nat Res Council Canada
Publication of CL2011002334A1 publication Critical patent/CL2011002334A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0003—Invertebrate antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43509—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from crustaceans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/80—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in fisheries management
    • Y02A40/81—Aquaculture, e.g. of fish

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Insects & Arthropods (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Vacuna recombinante contra infección por caligid (piojo marino) en peces que comprende proteínas de secreción similares a vitellogenina (sep).
CL2011002334A 2004-07-28 2011-09-21 Vacuna recombinante contra infeccion por caligid ( piojo marino ) en peces que comprende proteinas de secrecion similares a vitellogenina ( sep ). (divisional solicitud n° 1917-05) CL2011002334A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59162604P 2004-07-28 2004-07-28

Publications (1)

Publication Number Publication Date
CL2011002334A1 true CL2011002334A1 (es) 2012-03-30

Family

ID=35785878

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011002334A CL2011002334A1 (es) 2004-07-28 2011-09-21 Vacuna recombinante contra infeccion por caligid ( piojo marino ) en peces que comprende proteinas de secrecion similares a vitellogenina ( sep ). (divisional solicitud n° 1917-05)

Country Status (10)

Country Link
US (1) US8207132B2 (es)
EP (8) EP2397553B1 (es)
CA (1) CA2575218C (es)
CL (1) CL2011002334A1 (es)
DK (2) DK2397553T3 (es)
ES (2) ES2575156T3 (es)
NO (1) NO342565B1 (es)
PL (1) PL2397553T3 (es)
PT (1) PT2397553E (es)
WO (1) WO2006010265A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200801034A (en) * 2005-10-05 2008-01-01 Intervet Int Bv Novel sea lice vaccine
WO2007146359A2 (en) * 2006-06-14 2007-12-21 Diversa Corporation Sea lice antigen vaccines
CU23634A1 (es) 2007-05-31 2011-02-24 Ct Ingenieria Genetica Biotech Secuencias de ácido nucleico y aminoácidos, y vacuna para el control de infestaciones por ectoparásitos en peces
WO2009067020A1 (en) 2007-11-19 2009-05-28 Calanus As Bioactive copepod-compositions, processes for the production thereof, and use thereof to prevent or treat hosts infested by phylogenetically similar ectoparasites
CA2873599A1 (en) * 2012-05-17 2013-11-21 Tecnovax Chile S.A. Peptides inducing an immune response against copepods and/or the development of a mucous shield in fish; vaccines, uses and methods for modulating the fish immune response and/or for inducing development of a mucous shield in fish
WO2017213520A1 (en) * 2016-06-10 2017-12-14 Aqua Health As Peptides for the inhibition of parasite infection
NO343723B1 (en) * 2016-06-10 2019-05-20 Aqua Health As Peptides for the inhibition of trypsin and sea lice infestation.
NO343281B1 (en) * 2016-12-30 2019-01-14 Aqua Health As Peptides for the inhibition of trypsin and sea lice infestation.
US20210061866A1 (en) 2018-01-25 2021-03-04 Benchmark Animal Health Limited Sea lice antigens and vaccines
GB201902425D0 (en) 2019-02-22 2019-04-10 Benchmark Animal Health Ltd Sea lice antigens and vaccines
EP3920964A1 (en) * 2019-02-04 2021-12-15 Benchmark Animal Health Limited Sea lice vaccines

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0332660A4 (en) 1986-11-24 1990-12-05 Genex Corporation Bioadhesives
AU8091694A (en) 1993-10-26 1995-05-22 United Biomedical Inc. Structured synthetic antigen libraries as diagnostics, vaccines and therapeutics
JPH07163361A (ja) 1993-12-14 1995-06-27 Kaiyo Bio Technol Kenkyusho:Kk ムラサキイガイ接着蛋白質遺伝子
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
US20020013955A1 (en) * 1998-06-10 2002-01-31 Sharon Ogden Production of recombinant protein in transgenic fish
AU2003229199A1 (en) 2002-05-31 2003-12-19 Alpharma As Liposome vaccine formulations for fin-fish
GB0513484D0 (en) 2005-07-01 2005-08-10 Accentus Plc Producing liquid hydrocarbons
TW200801034A (en) * 2005-10-05 2008-01-01 Intervet Int Bv Novel sea lice vaccine

Also Published As

Publication number Publication date
DK2405003T3 (en) 2015-09-21
ES2575156T3 (es) 2016-06-24
PT2397553E (pt) 2016-06-08
DK2397553T3 (en) 2016-06-13
EP2397553B1 (en) 2016-05-04
CA2575218C (en) 2013-07-09
EP2405004A1 (en) 2012-01-11
EP1789554A1 (en) 2007-05-30
EP1789554A4 (en) 2009-05-06
WO2006010265A1 (en) 2006-02-02
EP2410055A1 (en) 2012-01-25
PL2397553T3 (pl) 2017-03-31
EP2407542A1 (en) 2012-01-18
EP2397552A1 (en) 2011-12-21
EP2405003B1 (en) 2015-09-02
EP2405003A1 (en) 2012-01-11
ES2548677T3 (es) 2015-10-20
US8207132B2 (en) 2012-06-26
EP2402445A1 (en) 2012-01-04
NO342565B1 (no) 2018-06-18
CA2575218A1 (en) 2006-02-02
EP2397553A1 (en) 2011-12-21
US20080003233A1 (en) 2008-01-03
EP1789554B1 (en) 2018-07-04
NO20071143L (no) 2007-02-28

Similar Documents

Publication Publication Date Title
CL2011002334A1 (es) Vacuna recombinante contra infeccion por caligid ( piojo marino ) en peces que comprende proteinas de secrecion similares a vitellogenina ( sep ). (divisional solicitud n° 1917-05)
BRPI0417684A (pt) composto, composição farmacêutica, e, uso de um composto
CO5720212A1 (es) Composicion de anticuerpo her2
LTC1687329I2 (lt) Optimizuotos HPV58 L1 raiška mielėse
BRPI0507169A (pt) polipeptìdeos do hormÈnio de crescimento humano modificados e seu usos
EA200701362A1 (ru) Агонисты glp-1, композиции, способы и применения
IS2659B (is) Þíasólidín-4-ón til að hamla gegn Hyak3 próteinum
AR074161A1 (es) Una calcomania de tatuaje temporal para aplicar enla piel de un usuario y configurada para detectar la presencia de un analito y metodo para detectar la presencia de un analito
CL2010001146A1 (es) Proteina recombinante de circovirus porcino tipo 2 (pcv2); uso de la proteina recombinante para prevenir una infección por pcv2; un envase que comprende la composición inmunogénica (div exp 3475-2005).
BRPI0510674A (pt) variantes fc otimizadas
CL2007001749A1 (es) Compuesto derivado de 2-arilamino-4-(heterociclo)aminopirimidina, inhibidores de la proteina quinasa c-alfa; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes, cancer, enfermedad cardiaca coronaria, aterosclerosis, entre otras.
BRPI0519046A2 (pt) composição de xampu
DE60309383D1 (de) Silberhaltige Dentalzusammensetzung
DK2327423T5 (da) Humane antistoffer mod humant interleukin-22 (IL-22)
CY1108430T1 (el) Χρηση ανταγωνιστων διαυλου νευρωνικου νατριου μαζι με αμιτραζ για τον ελεγχο εκτοπαρασιτων σε ομοιοθερμικα ζωα
AR113492A2 (es) Furina recombinante libre de proteínas sustancialmente animal y métodos para producirla
ECSP066916A (es) Vacuna contra estreptococo agalactiae
DE602006013190D1 (de) Haarbehandlungszusammensetzung mit einem kontaktkleber
EP1797117A4 (en) CLONING AND EXPRESSION OF THE RECOMBINANT ADHESION PROTEIN MEFP-1 FROM THE MUSSEL MYTILUS EDULIS
CL2012001657A1 (es) Polipeptidos de somatotropina porcina porque comprende un aminoacido no codificado de manera natural; uso de dicho polipeptido porque sirve para prevenir infeccion en animal.
ES2530670T3 (es) Anticuerpo anti-FGF23 y composición farmacéutica que comprende el mismo
SV2006002296A (es) Tratamiento de mastitis ref. bhc041335-sv
BRPI0707420A8 (pt) composições contendo peptídeos com aminoácidos e métodos não naturais do uso
UY30629A1 (es) Nuevo péptido de actinomadura namibiensis
UY28154A1 (es) Composiciones y metodos de cuidado oral